WO2015018127A1 - 一种降血脂的中药制剂及其制备方法 - Google Patents
一种降血脂的中药制剂及其制备方法 Download PDFInfo
- Publication number
- WO2015018127A1 WO2015018127A1 PCT/CN2013/085128 CN2013085128W WO2015018127A1 WO 2015018127 A1 WO2015018127 A1 WO 2015018127A1 CN 2013085128 W CN2013085128 W CN 2013085128W WO 2015018127 A1 WO2015018127 A1 WO 2015018127A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- chinese medicine
- preparation
- polygonum
- rhubarb
- alisma
- Prior art date
Links
- 239000003814 drug Substances 0.000 title claims abstract description 53
- 238000002360 preparation method Methods 0.000 title claims abstract description 48
- 230000000055 hyoplipidemic effect Effects 0.000 title abstract description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 41
- 210000004369 blood Anatomy 0.000 claims abstract description 37
- 239000008280 blood Substances 0.000 claims abstract description 37
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 33
- 235000008100 Ginkgo biloba Nutrition 0.000 claims abstract description 27
- 244000194101 Ginkgo biloba Species 0.000 claims abstract description 27
- 235000009411 Rheum rhabarbarum Nutrition 0.000 claims abstract description 26
- 240000001341 Reynoutria japonica Species 0.000 claims abstract description 25
- 235000018167 Reynoutria japonica Nutrition 0.000 claims abstract description 25
- 150000002632 lipids Chemical class 0.000 claims abstract description 15
- 241001289529 Fallopia multiflora Species 0.000 claims abstract description 11
- 241000305491 Gastrodia elata Species 0.000 claims abstract description 10
- 239000008213 purified water Substances 0.000 claims abstract description 7
- 238000000034 method Methods 0.000 claims abstract description 3
- 241000132446 Inula Species 0.000 claims abstract 7
- 241000244365 Ligusticum sinense Species 0.000 claims abstract 7
- 238000003756 stirring Methods 0.000 claims abstract 3
- 230000000694 effects Effects 0.000 claims description 39
- 244000037364 Cinnamomum aromaticum Species 0.000 claims description 27
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims description 27
- 241000219061 Rheum Species 0.000 claims description 25
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 claims description 24
- 244000035851 Chrysanthemum leucanthemum Species 0.000 claims description 24
- 241000748223 Alisma Species 0.000 claims description 20
- 239000000203 mixture Substances 0.000 claims description 19
- 235000018905 epimedium Nutrition 0.000 claims description 17
- 241000893536 Epimedium Species 0.000 claims description 15
- 241001061264 Astragalus Species 0.000 claims description 14
- 235000006533 astragalus Nutrition 0.000 claims description 14
- 210000004233 talus Anatomy 0.000 claims description 14
- 240000004731 Acer pseudoplatanus Species 0.000 claims description 10
- 235000002754 Acer pseudoplatanus Nutrition 0.000 claims description 10
- 241000361919 Metaphire sieboldi Species 0.000 claims description 10
- 235000006485 Platanus occidentalis Nutrition 0.000 claims description 10
- 241000305492 Gastrodia Species 0.000 claims description 8
- 241001412225 Firmiana simplex Species 0.000 claims description 7
- 244000046146 Pueraria lobata Species 0.000 claims description 7
- 235000010575 Pueraria lobata Nutrition 0.000 claims description 7
- 239000000843 powder Substances 0.000 claims description 6
- 235000011201 Ginkgo Nutrition 0.000 claims description 4
- 206010021024 Hypolipidaemia Diseases 0.000 claims description 2
- 208000031226 Hyperlipidaemia Diseases 0.000 abstract description 19
- 210000004185 liver Anatomy 0.000 abstract description 15
- 208000024891 symptom Diseases 0.000 abstract description 10
- 208000002173 dizziness Diseases 0.000 abstract description 8
- 206010062717 Increased upper airway secretion Diseases 0.000 abstract description 5
- 208000026435 phlegm Diseases 0.000 abstract description 5
- 230000001225 therapeutic effect Effects 0.000 abstract description 5
- 239000007788 liquid Substances 0.000 abstract description 4
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 abstract description 3
- 230000001914 calming effect Effects 0.000 abstract description 3
- 206010022437 insomnia Diseases 0.000 abstract description 3
- 206010027175 memory impairment Diseases 0.000 abstract description 3
- 235000013291 Alisma plantago aquatica Nutrition 0.000 abstract 1
- 240000004615 Alisma plantago-aquatica Species 0.000 abstract 1
- 244000277285 Cassia obtusifolia Species 0.000 abstract 1
- 235000006719 Cassia obtusifolia Nutrition 0.000 abstract 1
- 240000005250 Chrysanthemum indicum Species 0.000 abstract 1
- 235000018959 Chrysanthemum indicum Nutrition 0.000 abstract 1
- 241000530115 Clerodendrum trichotomum Species 0.000 abstract 1
- 241001362421 Epimedium brevicornu Species 0.000 abstract 1
- 241000237636 Pheretima Species 0.000 abstract 1
- 244000299790 Rheum rhabarbarum Species 0.000 abstract 1
- 240000004534 Scutellaria baicalensis Species 0.000 abstract 1
- 235000017089 Scutellaria baicalensis Nutrition 0.000 abstract 1
- 241000316341 Taxillus chinensis Species 0.000 abstract 1
- 230000001131 transforming effect Effects 0.000 abstract 1
- 241000219780 Pueraria Species 0.000 description 19
- 240000000249 Morus alba Species 0.000 description 16
- 235000008708 Morus alba Nutrition 0.000 description 16
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 14
- 238000011282 treatment Methods 0.000 description 14
- 241000205407 Polygonum Species 0.000 description 12
- 230000003071 parasitic effect Effects 0.000 description 11
- 206010012735 Diarrhoea Diseases 0.000 description 8
- 102000007330 LDL Lipoproteins Human genes 0.000 description 8
- 108010007622 LDL Lipoproteins Proteins 0.000 description 8
- 206010019233 Headaches Diseases 0.000 description 7
- 230000017531 blood circulation Effects 0.000 description 7
- 231100000869 headache Toxicity 0.000 description 7
- 210000003734 kidney Anatomy 0.000 description 7
- 239000002994 raw material Substances 0.000 description 7
- 108010023302 HDL Cholesterol Proteins 0.000 description 6
- 108010010234 HDL Lipoproteins Proteins 0.000 description 6
- 102000015779 HDL Lipoproteins Human genes 0.000 description 6
- 208000002193 Pain Diseases 0.000 description 6
- 235000012000 cholesterol Nutrition 0.000 description 6
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 6
- 208000012886 Vertigo Diseases 0.000 description 5
- 235000009508 confectionery Nutrition 0.000 description 5
- 238000001784 detoxification Methods 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 231100000862 numbness Toxicity 0.000 description 5
- 229940126680 traditional chinese medicines Drugs 0.000 description 5
- 231100000889 vertigo Toxicity 0.000 description 5
- 206010010904 Convulsion Diseases 0.000 description 4
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 description 4
- 235000019658 bitter taste Nutrition 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 210000003414 extremity Anatomy 0.000 description 4
- 229930003935 flavonoid Natural products 0.000 description 4
- 150000002215 flavonoids Chemical class 0.000 description 4
- 235000017173 flavonoids Nutrition 0.000 description 4
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 4
- 240000002900 Arthrospira platensis Species 0.000 description 3
- 235000016425 Arthrospira platensis Nutrition 0.000 description 3
- 208000024172 Cardiovascular disease Diseases 0.000 description 3
- 102000002045 Endothelin Human genes 0.000 description 3
- 108050009340 Endothelin Proteins 0.000 description 3
- 244000068988 Glycine max Species 0.000 description 3
- 235000010469 Glycine max Nutrition 0.000 description 3
- 241000282414 Homo sapiens Species 0.000 description 3
- 206010023126 Jaundice Diseases 0.000 description 3
- 230000003276 anti-hypertensive effect Effects 0.000 description 3
- 230000036461 convulsion Effects 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 230000035622 drinking Effects 0.000 description 3
- 230000002526 effect on cardiovascular system Effects 0.000 description 3
- ZUBDGKVDJUIMQQ-UBFCDGJISA-N endothelin-1 Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(O)=O)NC(=O)[C@H]1NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@@H](CC=2C=CC(O)=CC=2)NC(=O)[C@H](C(C)C)NC(=O)[C@H]2CSSC[C@@H](C(N[C@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N2)=O)NC(=O)[C@@H](CO)NC(=O)[C@H](N)CSSC1)C1=CNC=N1 ZUBDGKVDJUIMQQ-UBFCDGJISA-N 0.000 description 3
- 206010016256 fatigue Diseases 0.000 description 3
- 231100000861 limb weakness Toxicity 0.000 description 3
- 208000027905 limb weakness Diseases 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 229940082787 spirulina Drugs 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 2
- 241001016310 Epimedium grandiflorum Species 0.000 description 2
- 206010019468 Hemiplegia Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 241000131091 Lucanus cervus Species 0.000 description 2
- 206010028372 Muscular weakness Diseases 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 2
- 206010047513 Vision blurred Diseases 0.000 description 2
- 229930188301 Yinyanghuo Natural products 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- LQGUBLBATBMXHT-UHFFFAOYSA-N chrysophanol Chemical compound C1=CC=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O LQGUBLBATBMXHT-UHFFFAOYSA-N 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 201000005577 familial hyperlipidemia Diseases 0.000 description 2
- 208000014617 hemorrhoid Diseases 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 235000021374 legumes Nutrition 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 235000014347 soups Nutrition 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 208000024794 sputum Diseases 0.000 description 2
- 210000003802 sputum Anatomy 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- TWCMVXMQHSVIOJ-UHFFFAOYSA-N Aglycone of yadanzioside D Natural products COC(=O)C12OCC34C(CC5C(=CC(O)C(O)C5(C)C3C(O)C1O)C)OC(=O)C(OC(=O)C)C24 TWCMVXMQHSVIOJ-UHFFFAOYSA-N 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 102000008873 Angiotensin II receptor Human genes 0.000 description 1
- 108050000824 Angiotensin II receptor Proteins 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- PLMKQQMDOMTZGG-UHFFFAOYSA-N Astrantiagenin E-methylester Natural products CC12CCC(O)C(C)(CO)C1CCC1(C)C2CC=C2C3CC(C)(C)CCC3(C(=O)OC)CCC21C PLMKQQMDOMTZGG-UHFFFAOYSA-N 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000037260 Atherosclerotic Plaque Diseases 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 208000014644 Brain disease Diseases 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 241001273783 Carex scoparia Species 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- VWDXGKUTGQJJHJ-UHFFFAOYSA-N Catenarin Natural products C1=C(O)C=C2C(=O)C3=C(O)C(C)=CC(O)=C3C(=O)C2=C1O VWDXGKUTGQJJHJ-UHFFFAOYSA-N 0.000 description 1
- 206010008469 Chest discomfort Diseases 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 239000010282 Emodin Substances 0.000 description 1
- RBLJKYCRSCQLRP-UHFFFAOYSA-N Emodin-dianthron Natural products O=C1C2=CC(C)=CC(O)=C2C(=O)C2=C1CC(=O)C=C2O RBLJKYCRSCQLRP-UHFFFAOYSA-N 0.000 description 1
- 208000032274 Encephalopathy Diseases 0.000 description 1
- 241000588722 Escherichia Species 0.000 description 1
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 description 1
- YOOXNSPYGCZLAX-UHFFFAOYSA-N Helminthosporin Natural products C1=CC(O)=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O YOOXNSPYGCZLAX-UHFFFAOYSA-N 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 241000266847 Mephitidae Species 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010028836 Neck pain Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 240000007930 Oxalis acetosella Species 0.000 description 1
- 235000008098 Oxalis acetosella Nutrition 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 240000002834 Paulownia tomentosa Species 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 240000004760 Pimpinella anisum Species 0.000 description 1
- 235000012550 Pimpinella anisum Nutrition 0.000 description 1
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 1
- NTGIIKCGBNGQAR-UHFFFAOYSA-N Rheoemodin Natural products C1=C(O)C=C2C(=O)C3=CC(O)=CC(O)=C3C(=O)C2=C1O NTGIIKCGBNGQAR-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 description 1
- 241000157352 Uncaria Species 0.000 description 1
- 240000004922 Vigna radiata Species 0.000 description 1
- 235000010721 Vigna radiata var radiata Nutrition 0.000 description 1
- 235000011469 Vigna radiata var sublobata Nutrition 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000035508 accumulation Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000009098 adjuvant therapy Methods 0.000 description 1
- 239000003470 adrenal cortex hormone Substances 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000001315 anti-hyperlipaemic effect Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N benzo-alpha-pyrone Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 208000024330 bloating Diseases 0.000 description 1
- 230000004531 blood pressure lowering effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000001906 cholesterol absorption Effects 0.000 description 1
- NZPQWZZXRKZCDU-UHFFFAOYSA-N chrysophanol Natural products Cc1cc(O)c2C(=O)c3c(O)cccc3Oc2c1 NZPQWZZXRKZCDU-UHFFFAOYSA-N 0.000 description 1
- 230000007012 clinical effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 150000004775 coumarins Chemical class 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- RHMXXJGYXNZAPX-UHFFFAOYSA-N emodin Chemical compound C1=C(O)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O RHMXXJGYXNZAPX-UHFFFAOYSA-N 0.000 description 1
- VASFLQKDXBAWEL-UHFFFAOYSA-N emodin Natural products OC1=C(OC2=C(C=CC(=C2C1=O)O)O)C1=CC=C(C=C1)O VASFLQKDXBAWEL-UHFFFAOYSA-N 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 230000003511 endothelial effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 231100000234 hepatic damage Toxicity 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- PFOARMALXZGCHY-UHFFFAOYSA-N homoegonol Natural products C1=C(OC)C(OC)=CC=C1C1=CC2=CC(CCCO)=CC(OC)=C2O1 PFOARMALXZGCHY-UHFFFAOYSA-N 0.000 description 1
- 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 description 1
- 230000036035 hypolipemia Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 230000008818 liver damage Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 230000000926 neurological effect Effects 0.000 description 1
- 229940100688 oral solution Drugs 0.000 description 1
- -1 oxime ester Chemical class 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- PKUBGLYEOAJPEG-UHFFFAOYSA-N physcion Natural products C1=C(C)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O PKUBGLYEOAJPEG-UHFFFAOYSA-N 0.000 description 1
- 239000003495 polar organic solvent Substances 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 229940016667 resveratrol Drugs 0.000 description 1
- 235000021283 resveratrol Nutrition 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- JXOHGGNKMLTUBP-HSUXUTPPSA-N shikimic acid Chemical compound O[C@@H]1CC(C(O)=O)=C[C@@H](O)[C@H]1O JXOHGGNKMLTUBP-HSUXUTPPSA-N 0.000 description 1
- JXOHGGNKMLTUBP-JKUQZMGJSA-N shikimic acid Natural products O[C@@H]1CC(C(O)=O)=C[C@H](O)[C@@H]1O JXOHGGNKMLTUBP-JKUQZMGJSA-N 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 229940126673 western medicines Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
Definitions
- the invention relates to a traditional Chinese medicine preparation for lowering blood fat, in particular to a formula and a preparation method of the traditional Chinese medicine preparation which relates to the blood lipid lowering action.
- cardiovascular disease As a common disease in human body, cardiovascular disease has become one of the major factors threatening the health of today's human beings.
- cardiovascular disease has become one of the major factors threatening the health of today's human beings.
- the pace of life and work has accelerated, and the development of eating habits has become more heated and hyperlipidized.
- the number of hyperlipidemia patients in the population is increasing.
- the object of the present invention is to provide a traditional Chinese medicine preparation for preventing and reducing hyperlipemia based on the above-mentioned deficiencies, combined with modern Chinese and Western medicine technology, and in particular to provide a formula and a preparation method for the traditional Chinese medicine preparation.
- the invention belongs to a traditional Chinese medicine compound medicine for clearing heat and calming liver, dissipating blood stasis and promoting blood circulation, and treating symptoms such as dizziness, fatigue, insomnia, forgetfulness and limb numbness caused by hyperlipemia, the invention can quickly achieve the lipid-lowering effect, and is non-toxic. With no side effects, the lipid-lowering effect is stable, the effect is stable, and the preparation process is simple and easy.
- the preparation of the invention is pure water, pueraria root, wild chrysanthemum, mulberry parasitic, rhubarb, cassia seed, astragalus, yinyanghuo, stag beetle, ginkgo biloba, earthworm, gastrodia elata, polygonum, chuanxiong, diarrhea, circumcision, polygonum cuspidatum a liquid preparation of a composition prepared from a brown sugar and a 65% ethanol solution, wherein the mass ratio of each component is:
- the preferred raw material quality ratio of the present invention is
- the present invention can also be used as a preferred raw material quality with purified water 6000g Pueraria 15g wild chrysanthemum 25g
- the preparation method of the above-mentioned hypolipidemic traditional Chinese medicine preparation comprises the following steps:
- the powder mixture of pueraria, wild chrysanthemum, mulberry parasitic, rhubarb, cassia seed, astragalus, yinyanghu, sylvestris sylvestris is added to pure water for three times, the first time adding 10 times the amount of water to cook half a Hours, the second time added 5 times the amount of water to cook for 20 minutes, the third time Decoction in 5 times water for 10 minutes, then combine the decoction and filter, and set aside;
- Ginkgo biloba, Dilong, Tianma, Polygonum, Rhizoma Chuanxiong, Alisma, Rotary Flower, Polygonum cuspidatum are proportioned, crushed by a pulverizer and passed through a 80 mesh sieve, and then baked at a high temperature of 50-70 ° C Dry, then naturally dry to room temperature for use;
- step 5 at room temperature, the above step 2) and the decoction obtained in step 4), and added 65% ethanol solution and stirred evenly, forming a Chinese medicine composition solution preparation;
- the prepared Chinese medicine composition solution preparation can be used for oral administration, and if it can be consumed once in the morning and evening and long-term drinking, the effect is better.
- the theoretical basis of the present invention is: Pueraria, a legume plant kudzu, is a common vegetable in some provinces and autonomous regions of southern China, and its taste is sweet and delicious, and is often used as a soup. Its main component is starch, and it also contains about 12% of flavonoids, including soybean (soybean) glutinous rice, soybean aglycone, puerarin and other 10 kinds; and contains carrots, amino acids, coumarins and the like.
- Pueraria is cool, sweet and pungent. It is a commonly used hurricane solution.
- Pueraria has a blocking effect on ⁇ receptor and angiotensin II receptor, and its curative effect is better than previous antihyperlipidemic drugs.
- Puerarin can significantly increase plasma endothelin (ET) levels to return to normal soon, so one of the mechanisms of puerarin treatment of hyperlipidemia may be to inhibit the excessive release of ET, promote endothelial recovery, and then stimulate PG12 synthetase activity.
- Significantly increased EC production of PG inhibits platelet aggregation and improves blood circulation. Large doses of puerarin can lower blood sugar and significantly lower serum cholesterol.
- the single-flavored decoction has a general effect, but it is very effective in combination with other traditional Chinese medicines of the present invention.
- Mulberry parasitic, bitter taste; sweet; sex, into the liver, kidney can be rheumatism, liver and kidney, nourishing blood, and is mainly used for sputum, blood, nourishment, liver and kidney deficiency caused by weak bones, waist Knee acid soft embolism, also commonly used in the treatment of liver and kidney yin deficiency type hyperlipidemia.
- Rhubarb the root and rhizome of the palm leaf rhubarb or Tanggut rhubarb. Excavated in the autumn, washed, dried, sliced. The main effects are diarrhea, attack, heat, and blood. Modern research also has a good effect of lowering blood fat, can make tea, but because of its obvious diarrhea, the spleen and stomach are used with caution. Also can not be used for a long time. If it is used by the elderly, the rhubarb can be steamed slightly. Then use it, which can better alleviate its strong nature. However, in combination with other traditional Chinese medicines of the present invention, the diarrhea effect is greatly weakened, and the lipid-lowering effect is not affected.
- Cassia a dry seed of the legume Cassia
- Chinese medicine believes that it can calm the liver and yang, clear the liver and eyesight. Often used for liver yang sputum, blurred vision and other symptoms. It can be used for dizziness and other diseases caused by high blood pressure and high blood fat. Modern research has confirmed that the base has obvious antihypertensive and lipid-lowering effects.
- Cassia is an effective Chinese medicine for lowering blood fat, which is the most commonly used drug in Chinese medicine. Modern scientific and technical analysis contains Cassia.
- Cassia is the main component of its blood lipid lowering. You can use the remedy to treat high blood fat and cook it. For example, when you cook the mung bean soup, you can add a little cassia seed to strengthen the blood-staining effect.
- Astragalus can clear away heat and detoxification, purging fire and detoxification, its taste bitter cold, effect digestion and accumulation, blood circulation and lipid-lowering, clearing heat and detoxification, purging fire and detoxification, dealing with hyperlipidemia of liver heat, clearing dizziness, headache The effect of bitterness and upset. Whether it is decoction or infusion, it has obvious antihypertensive and lipid-lowering effects. It is compatible with wild chrysanthemum and Polygonum multiflorum for the treatment of neurological hyperlipidemia and arteriosclerosis and hyperlipidemia. It can cause hypolipemia, headache, chest tightness and impetuous symptoms. Improve and disappear.
- Epimedium alias iron arrow, horn flower, long green grass, born in a damp ravine, hillside forest or bamboo clumps, warm, sweet and fragrant, tonifying kidney, strong bones, rheumatism.
- muscles and tendons For impotence and nocturnal emission, muscles and tendons, rheumatism, numbness, numbness; menopausal hyperlipidemia and other symptoms.
- the stinky paulownia is also known as Haizhou Changshan, Taishan Red Five Star, Bubble Flower Tong, Star Aniseed Sycamore, Chasing Wind, Back Court Flower, etc. It is pungent, bitter, sweet, cool, into the liver, gallbladder, spleen.
- Ginkgo biloba leaves Ginkgo biloba leaves contain shikimic acid, ginkgo flavonoids, flavonoids, alcohol and other ingredients.
- Experimental studies and clinical trials have shown that Ginkgo biloba leaves have the effect of lowering serum cholesterol and dilating coronary arteries. It has a certain effect on the treatment of hypertension, hyperlipidemia and coronary heart disease.
- Shouwu can also prevent cholesterol from depositing in the liver, staying in the serum or penetrating into the intima of the artery to slow the formation of atherosclerosis. Decreased blood lipids may be associated with the combination of Shouwu active ingredients and cholesterol. Shouwu with ginkgo leaves, Uncaria and other treatments for cardiovascular and cerebrovascular diseases can eliminate or improve symptoms. Shouwu has side effects of diarrhea in individual patients. In addition, Shouwu leachate may contain adrenal cortex hormone analogues. Chuanxiong, a kind of traditional Chinese medicine plant, is often used for promoting blood circulation, relieving pain and relieving pain. It is mainly cultivated in Sichuan, Yunnan, Guizhou, Guangxi, Hubei and other places.
- the effect of promoting blood circulation is broad, suitable for blood stasis and blocking various diseases; hurricane and pain relief, good effect, can cure head wind headache, rheumatism and pain.
- Chuanxiong was a gas medicine in the blood, and it was said that it had functions such as disintegration, depression, accessibility, and pain relief.
- Alisma the rhizome of the genus Escherichia. Chinese medicine believes that it can dilute water. Modern research can reduce blood fat. It is an effective lipid-lowering Chinese medicine. The diarrhea taste is bitter and it is difficult to take.
- Rotating flowers also known as sedge grass, shamrock.
- Herbs perennial stems with longitudinal edges, green or microstriped purplish red. Leaves alternate, elliptic, elliptical-lanceolate or narrowly oblong.
- the heads are few or many, terminal, arranged in an umbrella-like shape.
- the flowers are salty, warm, and slightly toxic. They are used to eliminate phlegm, qi, soft and water.
- Polygonum cuspidatum medicinal root, mild temperature, with blood circulation, dampness function, traditionally used to treat rheumatism, phlegm, jaundice, amenorrhea, dysmenorrhea, etc.
- Polygonum cuspidatum contains various components of terpenoids and flavonoids, and can extract resveratrol with hypolipidemic components from its rhizome.
- Related experiments have shown that Polygonum cuspidatum has the effect of lowering cholesterol and triglycerides. 65% ethanol solution contains alcohol. Liquor is known as "the longest of 100 medicines".
- the liquor is stable, safe and effective, and because alcohol is a good semi-polar organic solvent, the various active ingredients of traditional Chinese medicine are soluble. Among them, the medicine exerts its effectiveness by means of alcohol and alcohol to help the drug, and improves the therapeutic effect.
- Chinese traditional Chinese medicine believes that hyperlipidemia is caused by emotional internal injuries, unhealthy diet, fatigue and fatigue, or due to old age, kidney loss, etc., leading to imbalance of yin and yang, wind and fire endogenous, phlegm and stasis, qi and blood Caused by chaos.
- Western medicine is also used to treat high blood lipids. Western medicine often has frequent dose reductions to achieve the target blood lipids. Therefore, there is often a phenomenon in which blood lipid rebound is large.
- the traditional Chinese medicine has a mild lipid-lowering effect and a stable blood lipid-lowering effect.
- the invention is particularly suitable for early, middle-aged and elderly hyperlipidemia patients, as well as heavier hyperlipidemia combined with the traditional Chinese medicine treatment of the present invention, and can also prevent a large rebound of blood lipids.
- the disease has a total cholesterol (TC) of 5. 2 ⁇ ol / L or more, a triglyceride (TG) of 1. 7 ⁇ ol / L or more, a low density lipoprotein (LDL - C) of 3. 12 mmol / L or more , high-density lipoprotein (HDL-C) below 1. 04mm O l / L, occasional head vertigo, blurred vision, limb weakness symptoms.
- TC total cholesterol
- TC total cholesterol
- TC total cholesterol
- TC total cholesterol
- TG triglyceride
- LDL - C low density lipoprotein
- HDL-C high-density lipoprotein
- the oral liquid of the preparation of the present invention is taken 1 hour after the meal, 3 times a day, 300 ml each time, and 1 month is a course of treatment, and two courses are observed as therapeutic effects.
- the beneficial effects of the present invention are that the preparation prepared by the invention can achieve the effects of clearing heat and calming the liver, reducing blood stasis, lowering blood lipids, treating head vertigo caused by hyperlipidemia, and weakness of limbs. Insomnia, forgetfulness and other symptoms, the invention can achieve the lipid-lowering effect quickly, and is non-toxic, has no side effects, has a stable lipid-lowering effect, and has stable effects, and the preparation process is simple and easy. Concrete implementation
- the preparation of the invention is pure water, pueraria root, wild chrysanthemum, mulberry parasitic, rhubarb, cassia seed, astragalus, yinyanghuo, stag beetle, ginkgo biloba, earthworm, gastrodia elata, polygonum, chuanxiong, diarrhea, circumcision, polygonum cuspidatum a liquid preparation of a composition prepared from a brown sugar and a 65% ethanol solution, wherein the mass ratio of each component is:
- the preparation method of the above-mentioned hypolipidemic traditional Chinese medicine preparation comprises the following steps:
- the powder mixture of pueraria, wild chrysanthemum, mulberry parasitic, rhubarb, cassia seed, astragalus, yinyanghu, sylvestris sylvestris is added to pure water for three times, the first time adding 10 times the amount of water to cook half a Hour, add 5 times the amount of water for 20 minutes, add 5 times the amount of water for 10 minutes, then combine the decoction and filter, set aside;
- Ginkgo biloba, Dilong, Gastrodia elata, Polygonum multiflorum, Rhizoma Chuanxiong, Alisma, Spirulina, and Polygonum cuspidatum are proportioned, crushed by a pulverizer and passed through a 80 mesh sieve, and then baked at a high temperature of 50-70 °C. Dry, then naturally dry to room temperature for use;
- the preparation of the above-mentioned traditional Chinese medicine composition solution can be used for oral administration, and if it can be consumed once in the morning and evening and long-term drinking, the effect is better.
- the preferred raw material quality of the present invention is (g):
- the preparation method is as in Example 1.
- the preferred raw material quality of the present invention is (g):
- the preferred raw material quality of the present invention is (g):
- the preparation method is as in Example 1.
- the preferred raw material quality of the present invention is (g):
- Example 6 The preferred raw material quality of the present invention is (g):
- the preparation method is as in Example 1.
- hypolipidemic preparation If the therapeutic effect of the hypolipidemic preparation is not affected, it will fall within the scope of the present invention.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
一种降血脂中药制剂,是由纯净水、葛根、野菊花、桑寄生、大黄、决明子、黄芩、淫羊藿、臭梧桐、银杏叶、地龙、天麻、何首乌、川芎、泽泻、旋覆花、虎杖、红糖和65%乙醇经粉碎、煎煮、混合、搅拌等工序制成液态制剂。该制剂能清热平肝、化痰活血,降低血脂,具有治疗高血脂引起的眩晕、四肢无力和失眠健忘等症状效果。
Description
一种降血脂的中药制剂及其制备方法 技术领域
本发明涉及一种降血脂作用的中药制剂,具体的说是涉及这种降 血脂作用的中药制剂的配方及制备方法。 背景技术
作为人身常见的一种疾病,心血管疾病已经成为威胁当今人类健 康的重大因素之一。近年来, 随着我国人口的老龄化以及人们生活水 平的提高, 生活、 工作节奏的加快, 饮食习惯向高热化、 高脂化方向 的发展, 人群中的高血脂患者呈递增趋势。
目前, 针对降血脂问题, 西药类降血脂药是他汀类为主导产品, 但是这些西药在降脂的同时, 会伴随有血糖升高、 恶心、 腹胀、 腹泻 以及肝功能损害等不良反应, 副作用非常明显。近些年来中药类心血 管病治疗制剂已逐渐成为国内市场上的畅销品种。 与西药制剂相比, 中药制剂具有 "多靶点、 多效应 "的特点, 因为中医理论认为, 人体 是一个整体, 故活血瘀类中药具有削除动脉粥样硬化斑块, 疏通血管 和加速血液循环等多种效果,因此中医类心血管病制剂与作用单一的 西药制剂相比更具优势。这表明我国广大病人对中药类心血管制剂临 床效果的认可, 但目前市场上的中药药物治疗有些治标不治本, 有些 使用价格昂贵的成分,很多产品降脂效果不明显,降脂后效果不稳定,
本发明的目的即在于针对上述不足, 在祖传秘方的基础上, 结合 现代中西医技术, 提供一种预防和降低高血脂的中药制剂, 具体的说 是提供这种中药制剂的配方和制备方法, 本发明属于一种清热平肝, 化痰活血, 主治高血脂引起的头晕、 神疲乏力、 失眠健忘、 肢体麻木 等症状的中药复方药物,本发明能够较快的达到降脂效果,而且无毒, 无副作用, 降脂作用平稳, 效果稳定, 制取工艺简便易行。
本发明的技术方案如下所述:
本发明制剂是由纯净水、葛根、野菊花、桑寄生、大黄、决明子、 黄苓、淫羊霍、臭梧桐、银杏叶、地龙、天麻、何首乌、川芎、泽泻、 旋复花、 虎杖、 红糖和 65%乙醇溶液制备成的组合物液态制剂, 其中 各组分的质量配比为:
纯净水 4000-8000g 葛根 10-30g 野菊花 20-40g 桑寄生 20-40g 大黄 25-35g 决明子 20-30g 黄苓 15-25g 淫羊藿 20-30g 悟桐 20-30g 银杏叶 20-30g 地龙 20-30g 天麻 30-40g 何首乌 30-40g 川芎 20-30g 泽泻 20-30g 旋复花 20-35g 虎杖 10-20g 红糖 20-30g
65%乙醇溶液 15-30g。
为了获得更好的效果, 本发明可优选的原料质量配比为
纯净水 5000-8000g 葛根 10-20g 野菊花 20-30g
桑寄生 20-30g 大黄 25-30g 决明子 20_25g 黄苓 15-20g 淫羊藿 20-25g 臭梧桐 20-25g 银杏叶 20-25g 地龙 20-25g 天麻 30-35g 何首乌 30-35g 川芎 20_25g 泽泻 20-25g 旋复花 20-30g 虎杖 10_20g 红糖 20-30g
65%乙醇溶液 15-25g。
当然, 为了获得进一步好的效果, 本发明还可优选的原料质量配 纯净水 6000g 葛根 15g 野菊花 25g
桑寄生 25g 大黄 25g 决明子 20g
黄芬 15g 淫羊藿 20g ic五桐 20g
银杏叶 25g 地龙 20g 天麻 30g
何首乌 30g 川芎 20g 泽泻 20g
旋复花 25g 虎杖 15g 红糖 30g
65%乙醇溶液 20g。
上述降血脂中药制剂的制备方法, 包括如下步骤:
1 )、 将葛根、 野菊花、 桑寄生、 大黄、 决明子、 黄苓、 淫羊霍、 捂桐按比例配好, 经过粉碎机粉碎并过 80目筛, 然后在 50— 70 °C 的高温下烘干, 然后自然晾到室温备用;
2 )、将上述步骤中葛根、野菊花、桑寄生、大黄、决明子、黄苓、 淫羊霍、 臭梧桐的粉末混合物加入纯净水煎煮三次, 第一次加入 10 倍量水煎煮半个小时, 第二次加入 5倍量水煎煮 20分钟, 第三次加
入 5倍量水煎煮 10分钟, 然后合并煎液并过滤, 备用;
3)、 将银杏叶、 地龙、 天麻、 何首乌、 川芎、 泽泻、 旋复花、 虎 杖按比例配好, 经过粉碎机粉碎并过 80目筛, 然后在 50— 70°C的高 温下烘干, 然后自然晾到室温备用;
4)、将上述银杏叶、地龙、天麻、何首乌、川芎、泽泻、旋复花、 虎杖的粉末混合物加入 10倍量的纯净水煎煮半个小时, 然后取煎液 并过滤, 备用;
5)、 在室温状态下, 将上述步骤 2 ) 和步骤 4) 中获得的煎液混 合, 并加入 65%乙醇溶液并搅拌均匀, 形成中药组合物溶液制剂;
6)、 将上述步骤 5) 中的中药组合物溶液制剂加入红糖, 并搅拌 5分钟, 即可制得。
制取的上述中药组合物溶液制剂可以用于口服,如果能够早中晚 各饮用一次并长期饮用, 效果更好。 本发明的理论依据在于: 葛根, 为豆科植物野葛, 是中国南方一些省区的一种常食蔬菜, 其味甘凉可口, 常作煲汤之用。 其主要成分是淀粉, 此外还含有约 12%的黄酮类化合物, 包括大豆 (黄豆) 甙、 大豆甙元、 葛根素等 10 余种;并含有胡萝卜甙、氨基酸、香豆素类等。作为中药,葛根性凉, 味甘、 辛, 是常用的祛风解表药, 临床报道用于治疗高血脂伴有颈项 强痛者疗效显着。 最新资料表明, 葛根具有 α 受体和血管紧张素 II 受体亦有阻断作用, 疗效优于以往各类抗高血脂药物。尤其可能逆转
高血脂所致的心肌肥厚。葛根素可使明显增高的血浆内皮素 (ET)水平 较快恢复正常, 故葛根素治疗高血脂病的机制之一可能在于能抑制 ET过量释放, 促进内皮恢复功能, 进而兴奋 PG12合成酶活性, 显著 增高 EC生成 PG抑制血小板聚集, 起到改善血液循环的作用。大剂量 葛根素能降低血糖, 能明显降低血清胆固醇。 但是单用葛根来降脂, 结果并不明显, 不过在本发明中和其他中药配伍来治疗高血脂病, 降 脂结果明显, 对高血脂引起的脑病, 头痛、 头晕、 肢麻、 耳鸣等症状 有很好的效果。 野菊花, 为菊科多年生草本植物野菊的头状花序, 外形与菊花相 似, 野生于山坡草地、 田边路旁。 野菊花可广泛用于清热解毒, 治疗 疔疮痈肿、 咽喉肿痛、 风火赤眼、 头痛眩晕等病证。 同时又有很好的 降压降脂作用, 可用于高血脂病的辅助治疗。 单味煎服效果一般, 但 是与本发明其他中药为伍, 则效果非常突出。 桑寄生, 味苦; 甘; 性平, 入肝、 肾经, 可以祛风湿, 补肝肾, 养血安胎, 主要用于痹症血不养筋、 肝肾不足所引起的筋骨萎弱、 腰 膝酸软等症, 亦常用于肝肾阴虚型高血脂病的治疗。 大黄, 为蓼科植物掌叶大黄或唐古特大黄的根及根茎。在秋季采 挖, 洗净, 晒干, 切片。 功效主要为泻下, 攻积, 清热, 凉血。 现代 研究也有较好的降血脂作用,可泡茶饮,但由于其有明显的致泻作用, 脾胃虚弱者慎用。也不能长期使用。 如果系老年人用, 可将大黄稍蒸
而后使用,这样能更好的缓解其俊烈之性。但与本发明其他中药为伍, 致泻作用大大减弱, 不影响降脂效果。 决明子,为豆科植物决明子的干燥种子,中医认为其能平肝潜阳, 清肝明目。 常用于肝阳上亢, 视物不清等症。 可用于高血压高血脂引 起的头晕等病。现代研究证实基有明显的降压降脂作用。决明子是一 种效果确切的降血脂中药, 在中成药降血脂药中是最常用的药物。现 代科学技术分析其含有决明子苷。 决明子苷是其降血脂的主要成份。 用决子治高血脂可以将其煮汤, 如在煮绿豆汤时可加入少许决明子, 加强了其洗血毒的作用。 黄苓, 可以清热解湿, 泻火解毒, 其味苦寒, 效用消食化积, 活 血降压降脂, 清热解湿, 泻火解毒, 对付肝经实热的高血脂病, 有清 除眩晕、 头痛、 口苦、 心烦的效用。 无论是煎剂、 浸剂, 均有较明显 的降压降脂效用, 与野菊花、何首乌等配伍治疗神经性高血脂和动脉 硬化高血脂病, 可使血脂低落, 头痛、 胸闷、 浮躁等症状明显改进和 消失。 淫羊藿, 别名铁箭头、 牛角花, 为长绿草木, 生于阴湿的山沟、 山坡杂林或竹丛中, 性温, 味辛甘, 补肾阳, 强筋骨, 祛风湿。 用于 阳痿遗精, 筋骨痿软, 风湿痹痛, 麻木拘挛; 更年期高血脂等症状。 臭梧桐又名海州常山、泰山红五星、泡花桐、八角梧桐、追骨风 、 后庭花等, 性辛、 味苦、 甘, 凉, 入肝经, 胆经, 脾经。 可以治疗风
湿痹痛, 半身不遂, 高血脂病, 偏头痛; 疟疾, 痢疾, 痔疮, 痈疽疮 疥。臭梧桐经高热煎煮后, 降压降脂作用减弱。但是与本发明中其他 中药配伍, 则药效不受影响。 银杏叶, 银杏叶含莽草酸、 白果双黄酮、 异白果双黄酮、 醇等 成分。 实验研究和临床试验证明, 银杏叶有降血清胆固醇、 扩张冠状 动脉的作用, 对治疗高血压、 高脂血症及冠心病有一定作用, 可单用 或配川芎、 红花等药物。 地龙, 性寒, 味咸。 可以清热定惊, 通络、 平喘, 利尿; 用于高 热神昏惊痫抽搐, 关节麻痹, 肢体麻木, 半身不遂, 肺热喘咳, 尿少 水肿, 高血脂症。 天麻, 为多年生草本植物, 分布于全国大部分地区。 其干燥块茎 亦称天麻, 是一味常用而较名贵的中药, 临床多用于头痛眩晕、 肢体 麻木、 小儿惊风、 癫痫、 抽搐、 破伤风等症, 可以平肝熄火, 适用于 肝阳上亢所致的头痛、 眩晕等症。 何首乌, 也叫首乌, 药用其干燥块根。 味苦、 甘、 涩, 性温, 归 肝、 肾二经。 首乌含丰富的卵憐脂、 淀粉等, 有助于脂肪运转。 首乌 含蒽酯衍生物, 主要为大黄酚及大黄泻素, 其次为大黄酸、 大黄素甲 醚等, 能使肠蠕动增强和抑制胆固醇吸收。首乌还能阻止胆固醇在肝 内沉积、在血清中滞留或渗透到动脉内膜中, 以减缓动脉粥样硬化形 成。血脂下降可能与首乌有效成分与胆固醇结合有关。首乌配银杏叶、
钩藤等治疗心脑血管病, 能消除或改善症状。首乌对个别病人有腹泻 的副作用。 另外, 首乌浸出液可能含有肾上腺皮质激素类似物。 川芎, 一种中药植物, 常用于活血行气, 祛风止痛, 主要栽培于 四川、 云南、 贵州、 广西、 湖北等地。 川芎辛温香燥, 走而不守, 既能行散, 上行可达巅顶; 又入血分, 下行可达血海。 活血祛瘀作用 广泛,适宜瘀血阻滞各种病症;祛风止痛,效用甚佳,可治头风头痛、 风湿痹痛等症。 昔人谓川芎为血中之气药, 殆言其寓辛散、 解郁、 通 达、 止痛等功能。 泽泻, 为泽泻科植物泽泻的根茎。 中医认为其能利水渗湿。现代 研究其能降血脂。 是有效的降血脂中药。 泽泻味较苦, 服用比较难, 在本发明中与其他中药为伍, 则苦味减弱, 不影响饮用效果。 旋复花, 又名驴儿草、 百叶草。 多年生草本, 茎具纵棱, 绿色或 微带紫红色。 叶互生, 椭圆形、 椭圆状披针形或窄长椭圆形。 头状花 序少数或多数, 顶生, 呈伞房状排列, 旋复花咸、 温、 有小毒, 用于 消痰, 下气, 软坚, 行水。 虎杖, 药用其根, 性微温, 具活血通经, 利湿功能, 传统用于治 疗风湿、 痹痛、 黄疸、 闭经、 痛经等。 据现代药理研究证明, 虎杖含 蒽醌类化合物和黄酮类多种成分,从其根茎中可提取具有降血脂成分 的白藜芦醇苷等。有关实验证明, 虎杖有降低胆固醇和甘油三酯的作 用。
65%乙醇溶液含酒精,白酒素有"百药之长"之称,白酒性质稳定、 安全有效, 而且因为酒精是一种良好的半极性有机溶剂, 中药的各种 有效成分都易溶于其中, 药借酒力、 酒助药势而充分发挥其效力, 提 高治疗效果。 我国中医认为, 高血脂病是因情志内伤、 饮食不节、 劳倦损伤, 或因年老体衰, 肾精亏损等导致脏腑阴阳平衡失调, 风火内生, 痰淤 交阻, 气血逆乱所致。 西药也治疗高血脂, 西医常常有为达到目标血 脂而频繁加减药量等情况, 因此, 也常常出现血脂反弹幅度较大的现 象。 而中药降脂作用缓和, 稳定血脂效果较好, 本发明尤其适用于早 期,中老年高血脂患者,以及较重的高血脂病配合本发明的中药治疗, 也可防止血脂较大反弹。 临床实验 1:
1 )、观察时间:在本发明技术方案未曾披露的情况下,选择 2013 年 1月到 2013年 3月的 3个月时间。
2 )、观察对象:在广东省深圳市中医院选择 10例病例:男 5例, 女 5例; 年龄: 45— 55岁 5例, 55— 75岁 5例; 职业: 民营企业主 5例, 退休人员 5例。 病情: 总胆固醇 (TC)在 5. 2匪 ol/L以上, 甘油 三酯(TG)在 1. 7匪 ol/L以上,低密度脂蛋白(LDL-C)在 3. 12匪 ol/L以 上, 高密度脂蛋白(HDL-C)在 1. 04匪 ol/L以下, 偶有头部眩晕, 目视 不清, 四肢无力症状。
3)、 使用方法: 将本发明制剂口服液在餐后 1小时服用, 每日 3 次, 每次 300ml, 1个月为 1疗程, 两个疗程作为疗效观察。
4)、 观察效果:
在连续服用两个疗程后, 其中 6 例患者降至总胆固醇 (TC)在 4. 9匪 ol/L 左右, 甘油三酯 (TG)在 1. 7匪 ol/L 左右, 低密度脂蛋白 (LDL-C)在 3. 12匪 ol/L以下,高密度脂蛋白(HDL-C)在 1. 04mmol/L以 上, 4例患者降至总胆固醇 (TC)在 4. 6匪 ol/L左右, 甘油三酯 (TG)在 1. 5匪 ol/L左右, 低密度脂蛋白(LDL-C)在 3. 00匪 ol/L以下, 高密度 脂蛋白(HDL-C)在 1. 10mmol/L以上,停药 7天后观察, 没有明显反弹 迹象,血脂平稳,头部眩晕消失, 目视不清、四肢无力状况大大改善。
临床实验 2:
1 )、观察时间: 在本发明技术方案未曾披露的情况下, 选择 2013 年 4月到 2013年 6月的 3个月时间。
2 )、 观察对象: 在广东省深圳市福田区中医院选择 10例病例: 男 6例, 女 4例; 年龄: 55— 65岁 5例, 65— 75岁 5例; 职业: 曾 担任岗位领导的肥胖型公务员 5例, 肥胖型普通退休公务员 5例。病 If : 总胆固醇(TC)在 5. 2匪 ol/L以上, 甘油三酯(TG)在 1. 7匪 ol/L以 上,低密度脂蛋白(LDL-C)在 3. 12mmol/L以上,高密度脂蛋白(HDL-C) 在 1. 04mmOl/L以下, 偶有头部眩晕, 目视不清, 四肢无力症状。
3)、 使用方法: 将本发明制剂口服液在餐后 1小时服用, 每日 3 次, 每次 300ml, 1个月为 1疗程, 两个疗程作为疗效观察。
4)、 观察效果:
在连续服用两个疗程后, 其中 4 例患者降至总胆固醇 (TC)在 4. 9匪 ol/L 左右, 甘油三酯 (TG)在 1. 7匪 ol/L 左右, 低密度脂蛋白 (LDL-C)在 3. 12匪 ol/L以下,高密度脂蛋白(HDL-C)在 1. 04mmol/L以 上, 6例患者降至总胆固醇 (TC)在 4. 6匪 ol/L左右, 甘油三酯 (TG)在 1. 5匪 ol/L左右, 低密度脂蛋白(LDL-C)在 3. 00匪 ol/L以下, 高密度 脂蛋白(HDL-C)在 1. 10mmol/L以上,停药 7天后观察, 没有明显反弹 迹象,血脂平稳,头部眩晕消失, 目视不清、四肢无力状况大大改善。
结合以上临床数据及本发明的理论依据,可见本发明有益效果在 于, 本发明制成的制剂, 可以达到清热平肝, 化痰活血, 降低血脂和 治疗高血脂引起的头部眩晕、 四肢无力、 失眠健忘等症状, 本发明能 够较快的达到降脂效果, 而且无毒, 无副作用, 降脂作用平稳, 效果 稳定, 制取工艺简便易行。 具体实舫式
下面结合实施例对本发明详细加以说明:
实施例 1:
本发明制剂是由纯净水、葛根、野菊花、桑寄生、大黄、决明子、 黄苓、淫羊霍、臭梧桐、银杏叶、地龙、天麻、何首乌、川芎、泽泻、 旋复花、 虎杖、 红糖和 65%乙醇溶液制备成的组合物液态制剂, 其中 各组分的质量配比为:
纯净水 4000g 葛根 10g 野菊花 20g
桑寄生 20g 大黄 25g 决明子 20g
黄芬 15g ic五桐 20g 银杏叶 20g 地龙 20g 天麻 30g
何首乌 30g 川芎 20g 泽泻 20g
旋复花 20g 虎杖 10g 红糖 20g
65%乙醇溶液 15g。
上述降血脂中药制剂的制备方法, 包括如下步骤:
1 )、 将葛根、 野菊花、 桑寄生、 大黄、 决明子、 黄苓、 淫羊霍、 捂桐按比例配好, 经过粉碎机粉碎并过 80目筛, 然后在 50— 70°C 的高温下烘干, 然后自然晾到室温备用;
2 )、将上述步骤中葛根、野菊花、桑寄生、大黄、决明子、黄苓、 淫羊霍、 臭梧桐的粉末混合物加入纯净水煎煮三次, 第一次加入 10 倍量水煎煮半个小时, 第二次加入 5倍量水煎煮 20分钟, 第三次加 入 5倍量水煎煮 10分钟, 然后合并煎液并过滤, 备用;
3 )、 将银杏叶、 地龙、 天麻、 何首乌、 川芎、 泽泻、 旋复花、 虎 杖按比例配好, 经过粉碎机粉碎并过 80目筛, 然后在 50— 70°C的高 温下烘干, 然后自然晾到室温备用;
4)、将上述银杏叶、地龙、天麻、何首乌、川芎、泽泻、旋复花、 虎杖的粉末混合物加入 10倍量的纯净水煎煮半个小时, 然后取煎液 并过滤, 备用;
5分钟, 即可制得。
制取的上述中药组合物溶液制剂可以用于口服,如果能够早中晚 各饮用一次并长期饮用, 效果更好。
实施例 2:
本发明还可优选的原料质量为 (克):
纯净水 8000g 葛根 30g 野菊花 40g
桑寄生 40g 大黄 35g 决明子 30g
黄苓 25g 淫羊藿 30g 臭梧桐 30g
银杏叶 30g 地龙 30g 天麻 40g
何首乌 40g 川芎 30g 泽泻 30g
旋复花 35g 虎杖 20g 红糖 30g
65%乙醇溶液 15g。
制备方法如实施例 1。
实施例 3:
本发明还可优选的原料质量为 (克):
纯净水 5000g 葛根 15g 野菊花 25g
桑寄生 25g 大黄 30g 决明子 25g
黄苓 20g 淫羊藿 25g 臭梧桐 25g
银杏叶 25g 地龙 25g 天麻 35g
何首乌 35g 川芎 25g 泽泻 25g
旋复花 25g 虎杖 15g 红糖 25g
65%乙醇溶液 20gc
制备方法如实施例 1
实施例 4:
本发明还可优选的原料质量为 (克):
纯净水 6000g 葛根 20g 野菊花 30g 桑寄生 30g 大黄 35g 决明子 30g 黄苓 25g 淫羊藿 30g 臭梧桐 30g 银杏叶 30g 地龙 30g 天麻 35g 川芎 30g 泽泻 30g 虎杖 20g 红糖 30g
25gc
制备方法如实施例 1。
实施例 5:
本发明还可优选的原料质量为 (克):
纯净水 7000g 葛根 10g 野菊花 20g 桑寄生 20g 大黄 25g 决明子 20g 黄苓 25g 淫羊藿 30g 臭梧桐 30g 银杏叶 30g 地龙 30g 天麻 30g 何首乌 30g 川芎 20g 泽泻 20g 旋复花 35g 虎杖 20g 红糖 20g 65%乙醇溶液 30gc
制备方法如实施例 1
实施例 6:
本发明还可优选的原料质量为 (克):
纯净水 4500g 葛根 12g 野菊花 28g
桑寄生 28 大黄 28g 决明子 26g
黄苓 18g 淫羊藿 22g 臭梧桐 22g
银杏叶 22g 地龙 22g 天麻 38g
何首乌 38g 川芎 21g 泽泻 21g
旋复花 23g 虎杖 12g 红糖 28g
65%乙醇溶液 18g。
制备方法如实施例 1。
上述实施例仅是本发明众多实施方式的几种,如将各配方按技术方案
I大或减小药量, 制得的这种降血脂制剂疗效并不受影响, 也将落在本发明的权利保护范围之内。
Claims
1、 一种降血脂中药制剂的配方, 其特征在于, 本发明制剂是由 纯净水、 葛根、 野菊花、 桑寄生、 大黄、 决明子、 黄苓、 淫羊霍、 臭 梧桐、 银杏叶、 地龙、 天麻、 何首乌、 川芎、 泽泻、 旋复花、 虎杖、 红糖和 65%乙醇溶液制备成的组合物液态制剂, 其中各组分的质量配 纯净水 4000-8000g 葛根 10-30g 野菊花 20-40g 桑寄生 20-40g 大黄 25-35g 决明子 20-30g 黄苓 15-25g 淫羊藿 20-30 臭梧桐 20-30g 银杏叶 20-30g 地龙 20- 30g 天麻 30-40g 何首乌 30-40g 川芎 20-30g 泽泻 20-30g 旋复花 20-35g 虎杖 10-20g 红糖 20-30g
65%乙醇溶液 30g o
2、 根据权利要求 1所述的降血脂中药制剂的配方, 其特征还在 于, 其中各组分的质量配比为:
纯净水 5000-8000g 葛根 10-20g 野菊花 20-30g 桑寄生 20-30g 大黄 25-30g 决明子 20-25g 黄苓 15-20g 淫羊藿 20-25g 臭梧桐 20-25g 银杏叶 20-25g 地龙 20-25g 天麻 30-35g 何首乌 30-35g 川芎 20-25g 泽泻 20-25g 旋复花 20-30g 虎杖 10_20g 红糖 20-30g
65%乙醇溶液 15-25g o
3、 根据权利要求 1或 2所述的降血脂中药制剂的配方, 其特征 还在于, 其中各组分的质量配比为:
纯净水 6000g 葛根 15g 野菊花 25g
桑寄生 25g 大黄 25g 决明子 20g
黄芬 15g 淫羊藿 20g ic五桐 20g
银杏叶 25g 地龙 20g 天麻 30g
何首乌 30g 川芎 20g 泽泻 20g
旋复花 25g 虎杖 15g 红糖 30g
65%乙醇溶液 20g。
4、 一种降血脂中药制剂的制备方法, 其特征在于, 其包括如下
1 )、 将葛根、 野菊花、 桑寄生、 大黄、 决明子、 黄苓、 淫羊霍、 臭梧桐按比例配好, 经过粉碎机粉碎并过 80目筛, 然后在 50— 70°C 的高温下烘干, 然后自然晾到室温备用;
2 )、将上述步骤中葛根、野菊花、桑寄生、大黄、决明子、黄苓、 淫羊霍、 臭梧桐的粉末混合物加入纯净水煎煮三次, 第一次加入 10 倍量水煎煮半个小时, 第二次加入 5倍量水煎煮 20分钟, 第三次加 入 5倍量水煎煮 10分钟, 然后合并煎液并过滤, 备用;
3 )、 将银杏叶、 地龙、 天麻、 何首乌、 川芎、 泽泻、 旋复花、 虎 杖按比例配好, 经过粉碎机粉碎并过 80目筛, 然后在 50— 70°C的高 温下烘干, 然后自然晾到室温备用;
4)、将上述银杏叶、地龙、天麻、何首乌、川芎、泽泻、旋复花.
虎杖的粉末混合物加入 10倍量的纯净水煎煮半个小时, 然后取煎液 并过滤, 备用;
5 )、 在室温状态下, 将上述步骤 2 ) 和步骤 4) 中获得的煎液混 合, 并加入 65%乙醇溶液并搅拌均匀, 形成中药组合物溶液制剂;
6 )、 将上述步骤 5 ) 中的中药组合物溶液制剂加入红糖, 并搅拌 5 分钟, 即可制得, 制取的上述中药组合物溶液制剂可以用于口服, 如果能够早中晚各饮用一次并长期饮用, 效果更好。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2013103439285A CN103417854A (zh) | 2013-08-09 | 2013-08-09 | 一种降血脂中药制剂的配方及制备方法 |
CN201310343928.5 | 2013-08-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2015018127A1 true WO2015018127A1 (zh) | 2015-02-12 |
Family
ID=49643594
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2013/085128 WO2015018127A1 (zh) | 2013-08-09 | 2013-10-12 | 一种降血脂的中药制剂及其制备方法 |
Country Status (2)
Country | Link |
---|---|
CN (2) | CN103417854A (zh) |
WO (1) | WO2015018127A1 (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108771690A (zh) * | 2018-08-23 | 2018-11-09 | 嘉应学院医学院 | 一种具有降血糖或降血脂作用的红冬蛇菰提取物及其制备方法和应用 |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104257910A (zh) * | 2014-10-26 | 2015-01-07 | 童皖晋 | 一种降血脂的中药制剂 |
CN108114235A (zh) * | 2016-11-30 | 2018-06-05 | 大同县科学技术开发交流服务中心 | 一种降血脂中药冲剂 |
CN108686007A (zh) * | 2018-08-28 | 2018-10-23 | 深圳市必发达科技有限公司 | 一种降血脂的中药组合物 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1628748A (zh) * | 2004-09-01 | 2005-06-22 | 于宝锋 | 降脂片及其制备方法 |
CN101455791A (zh) * | 2008-11-27 | 2009-06-17 | 朱新华 | 治疗高血脂的纯中药制剂 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101274084A (zh) * | 2007-12-18 | 2008-10-01 | 秦庆吉 | 治疗高血压和高血脂及其并发症的药物 |
CN101721563A (zh) * | 2009-11-09 | 2010-06-09 | 徐兆云 | 三高康复茶 |
-
2013
- 2013-08-09 CN CN2013103439285A patent/CN103417854A/zh active Pending
- 2013-10-12 WO PCT/CN2013/085128 patent/WO2015018127A1/zh active Application Filing
-
2014
- 2014-08-08 CN CN201410388421.6A patent/CN104189520B/zh not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1628748A (zh) * | 2004-09-01 | 2005-06-22 | 于宝锋 | 降脂片及其制备方法 |
CN101455791A (zh) * | 2008-11-27 | 2009-06-17 | 朱新华 | 治疗高血脂的纯中药制剂 |
Non-Patent Citations (3)
Title |
---|
HE, GUOYUN ET AL.: "Research Progress on Inula", MEDICAL INNOVATION OF CHINA, vol. 9, no. 27, September 2012 (2012-09-01), pages 61 - 163 * |
QU, JIANHONG ET AL.: "Preparation and Applications of Five-Leaf Delightful Tea", CHINA 'S NATUROPATHY, vol. 9, no. 8, August 2001 (2001-08-01), pages 55 - 56 * |
TAO, YUNHAI; ET AL.: "Wu Fuchang's Experience in Treating Hyperlipidemia", ZHEJIANG JOURNAL OF TRADITIONAL CHINESE MEDICINE, vol. 46, no. 9, September 2011 (2011-09-01), pages 636 - 637 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108771690A (zh) * | 2018-08-23 | 2018-11-09 | 嘉应学院医学院 | 一种具有降血糖或降血脂作用的红冬蛇菰提取物及其制备方法和应用 |
CN108771690B (zh) * | 2018-08-23 | 2021-10-29 | 嘉应学院 | 一种具有降血糖或降血脂作用的红冬蛇菰提取物及其制备方法和应用 |
Also Published As
Publication number | Publication date |
---|---|
CN103417854A (zh) | 2013-12-04 |
CN104189520A (zh) | 2014-12-10 |
CN104189520B (zh) | 2015-11-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2015018129A1 (zh) | 一种降血压中药制剂及其制备方法 | |
CN104138529B (zh) | 一种降血脂中药制剂及其制备方法 | |
WO2015018127A1 (zh) | 一种降血脂的中药制剂及其制备方法 | |
WO2015018128A1 (zh) | 一种降血糖的中药制剂及其制备方法 | |
WO2015018124A1 (zh) | 一种降血压中药制剂及其制备方法 | |
CN105266149A (zh) | 一种铁皮石斛复方保健胶囊及其制备方法 | |
CN104056138A (zh) | 一种用于治疗单纯性甲状腺肿的中药及其制备方法 | |
CN104472798A (zh) | 一种降高血糖凉茶及其制备方法 | |
CN105435197A (zh) | 一种治疗桥本氏病的药物组合物及其制备方法 | |
CN109315558A (zh) | 一种姜枣茶泡腾片及其制备方法 | |
CN104397236A (zh) | 平胃养生中药茶饮品及制备方法 | |
CN111329983B (zh) | 一种含有忧遁草的中药组合物及其制备方法 | |
CN113797294A (zh) | 一种治疗萎缩性胃炎的药物组合物及制备方法 | |
CN105560987A (zh) | 医治冻疮的中药组合物及制法 | |
CN104771553A (zh) | 治疗胃癌的健脾补肾制剂及制备方法 | |
CN104435969A (zh) | 治疗小儿疳积的健胃消食饮及其制备方法 | |
CN108686007A (zh) | 一种降血脂的中药组合物 | |
CN106490092A (zh) | 一种咖啡风味保健蛋糕及制作方法 | |
CN105663266A (zh) | 治疗气滞血瘀所致的胃痛、胁痛、头痛及痛经的中药组合物 | |
CN105412673A (zh) | 一种治疗桥本氏病的药物及其制备方法 | |
CN104707003B (zh) | 治疗高血压、高血脂的中药胶囊 | |
CN118576668A (zh) | 沉香香灸及其制作工艺、使用方法 | |
CN103736054A (zh) | 一种保护胃黏膜的中药组合物及其制备方法 | |
CN115505472A (zh) | 喜树人参养生酒酿造工艺 | |
CN105918519A (zh) | 一种双花益智仁夏季养生袋泡茶及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 13891223 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 25/07/2016) |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 13891223 Country of ref document: EP Kind code of ref document: A1 |